PharmaWatch Canada details the paradoxes of off-label prescribing, in which doctors may prescribe but pharmaceutical companies may not promote medication for conditions for which they have not been tested or approved.
Support MIA
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.